companydata.dkcompanydata.dk

Mammen BioProcess Support ApS: Financial statements 2026

CVR: 43983881

Source: annual report 2026, Danish Business Authority

01/04/2025 – 31/03/2026

Mammen BioProcess Support ApS (CVR 43983881) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. That is an increase of 19.1% compared with the year before. Equity in the 2026 report amounted to DKK 670,757. The solvency ratio was 72.8%.

Gross Profit
DKK 1,787,690
Profit/Loss
DKK 362,902
Equity
DKK 670,757
Total Assets
DKK 920,905
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026-1.8M363K671K0
2025-1.5M261K308K0
2024-1.6M436K476K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Mammen BioProcess Support ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

About Mammen BioProcess Support ApS

Mammen BioProcess Support ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2023. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder. The management consists of Max Løjtved Mammen. The company is owned by Max Mammen Holding ApS. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. Equity in the 2026 report amounted to DKK 670,757.

Source: annual report 2026, Danish Business Authority

Other financial years